Previous studies have reported that SDF-1α and its receptor, CXCR4, or SDF-1/CXCR4 axis was cardioprotective after myocardial infarction, including attenuation of adverse ventricular remodelling and preservation of ventricular function [23, 24]. This evidence concerns the gene CXCL12 and myocardial infarction.